What is diabetic retinopathy? Diabetic retinopathy, or glycoplasia for short, is a complication of diabetes that causes bleeding in the fundus, retinal detachment, and eventually blindness. Generally speaking, diabetic retinopathy may develop in varying degrees after 3-5 years of diabetes, and almost 100% of people with 15 years of disease develop retinopathy. How to detect diabetic retinopathy? Diabetic patients with varying degrees of vision loss, flashing sensation in front of the eyes, distortion of vision, black shadows in front of the eyes, etc. indicate that they may already have glycogen retinopathy, which should be examined and actively treated in a timely manner, otherwise their vision will further decline and eventually cause fundus hemorrhage, retinal detachment and blindness. What does diabetic retinopathy look like? Red microangiomas and hemorrhages, yellowish-white exudates and white cotton wool spots, proliferation of neovascularization and fibrovascularity are seen on the retina, which can cause vitreous hemorrhage and retinal detachment. Most patients will develop vitreous hemorrhage and become blind within 1-2 years. Early prevention of diabetic retinopathy is needed. Patients with early detection and treatment of diabetic retinopathy may have unaffected vision, while in the middle stage, laser retinal photocoagulation with medication is needed to protect central vision and avoid blindness. If vitreous hemorrhage and retinal detachment occur in advanced stages, vitrectomy is required and the rate of recovery is poor, so early prevention and treatment is important. Patients with diabetes should have their fundus examined annually, once every 5 years after the onset of type 1 diabetes and once every year from the time of diagnosis for type 2 diabetes. Gospel of diabetic retinopathy: For timely and effective intervention and early treatment of patients with diabetic retinopathy, our hospital has opened a special diabetic eye clinic with dedicated staff to establish medical records and database for regular follow-up of patients with retinopathy.